557
Views
30
CrossRef citations to date
0
Altmetric
Research Paper

Inhibition of hsp27 and hsp40 potentiates 5-fluorouracil and carboplatin mediated cell killing in hepatoma cells

Pages 2106-2113 | Published online: 15 Nov 2009
 

Abstract

Heat shock proteins (Hsps) modulate several cellular functions and are

ubiquitously present in cell. Here, we investigated alterations in the

expression of Hsps and explored functional consequences of the same.

Moreover, effect of quercetin (Qctn), an inhibitor of Hsps, on

chemotherapeutic drugs treatment in hepatoma cells Hep3B and HepG2 was

investigated. We for the first time report that 5-fluorouracil (5-FU) and

carboplatin specifically induce expression of Hsp40 in addition to Hsp27 in

Hep3B and HepG2 cells. Induction of Hsps following exposure to sub lethal

dose of drugs is a cellular challenge to survival. However, under lethal

environmental conditions with reduced cell viability, cells fail to sustain the

induction of survival proteins, Hsp27 and Hsp40.  Though Qctn itself, to

certain extent is cytotoxic to cells, it potentiates the pro-apoptotic action of 5-

FU and carboplatin, by inhibiting expression of Hsps. The increased cell killing

correlates with decreased levels of procaspase-3. Furthermore, siRNA

mediated knockdown of Hsp27 and Hsp40 diminishes survival of drugs

exposed cells. Altogether, our data provides clear evidence that Hsp27 and

40 promote cell survival and inhibition of their expression does not allow cells

to adapt to drug exposure and survive. Collectively, our novel findings on

compelling action of 5-FU or carboplatin following knockdown of Hsp40 and

that of Hsp27 highlights their strategic implications towards an effective

therapy against HCC.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.